Orbital Retinoblastoma: From Palliation to Cure by Sequential Multimodal Multidisciplinary Therapy – A Case Report
Authors:
- Victoria Wen Wei NgVNVictoria Wen Wei Ng
- Darren Ngiap Hao TanDTDarren Ngiap Hao Tan
- Miriam Santiago KimpoMKMiriam Santiago Kimpo
- Wen Shen LooiWLWen Shen Looi
- Derrick LianDLDerrick Lian
- Gangadhara SundarGSGangadhara Sundar
Open Access
- 26 December 2025
- journal article
- Published by S. Karger AG in Case Reports in Oncology
- Vol. 19 (1) , 176-183
Abstract
Introduction: Orbital retinoblastoma (RB) is a form of advanced-stage RB and typically carries poor prognosis, with mortality rates ranging from 25% to 100% [Br J Ophthalmol. 1990;74(2):97–8]. While new multimodal treatment protocols have been proposed, there remains a paucity of reported successful treatment outcomes before standard treatment protocols can be established. In many developing nations, orbital RB is frequently palliated due to presumed poor treatment outcomes. Case Presentation: We highlight a case of a 6-year-old child who presented with a unilateral fungating orbital RB without regional or systemic spread. After 4 cycles of neoadjuvant chemotherapy, there was complete clinical regression of the tumour to within the globe. Following an ocular enucleation with histopathologic control, he underwent placement of a primary orbital implant followed by adjuvant proton beam therapy (PBT) to the orbit and remains well till this day. Conclusion: This case underscores the importance of multimodal combination therapy in improving survival outcomes, highlighting the promising impact of neoadjuvant systemic chemotherapy in reducing tumour burden even in advanced RB. It also draws attention to the use of PBT as a superior alternative to conventional external beam radiotherapy, due to its ability to reduce dose splash to surrounding organs, reducing the chance of secondary malignancies [Indian J Ophthalmol. 2024;72(6):778–88]. Above all, this case challenges the historical prognosis of orbital RB, demonstrating that with a tailored and comprehensive approach, even children with advanced disease can attain disease-free survival. It serves as a call to action for the clinical community to continue pursuing evidence-based treatment protocols that can transform advanced RB care.Keywords
This publication has 15 references indexed in Scilit:
- Intensive Multimodality Therapy for Extraocular Retinoblastoma: A Children's Oncology Group Trial (ARET0321)Journal of Clinical Oncology, 2022
- Response criteria for intraocular retinoblastoma: RB‐RECISTPediatric Blood & Cancer, 2021
- RetinoblastomaPediatric Clinics of North America, 2015
- Treatment of Retinoblastoma: The Role of External Beam RadiotherapyYonsei Medical Journal, 2015
- Second nonocular tumors among survivors of retinoblastoma treated with contemporary photon and proton radiotherapyCancer, 2013
- Orbital retinoblastoma: Present status and future challenges – A reviewSaudi Journal of Ophthalmology, 2011
- Clinical presentation of retinoblastoma in Eastern NepalClinical & Experimental Ophthalmology, 2005
- Outcome Following Initial External Beam Radiotherapy in Patients WithReese-Ellsworth Group Vb RetinoblastomaArchives of Ophthalmology (1950), 2004
- Retinoblastoma in Taiwan Survival and Clinical Characteristics 1978–2000Japanese Journal of Ophthalmology, 2002
- Orbital recurrence of retinoblastoma successfully treated by combined therapy.British Journal of Ophthalmology, 1990